These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 26869206)
1. [Status of cardiac resynchronization therapy in Catalonia, Spain: Results of the prospective multicentric study TRC-CAT]. Trucco ME; Tolosana JM; Arbelo E; Méndez FJ; Viñolas X; Anguera I; Dallaglio P; Villuendas R; Pereferrer Kleiner D; Pérez-Rodon J; Roca-Luque I; Mercé J; Badarjí A; Martí Almor J; Vallés E; Berruezo A; Sitges M; Brugada J; Mont L Med Clin (Barc); 2016 May; 146(10):423-8. PubMed ID: 26869206 [TBL] [Abstract][Full Text] [Related]
2. Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy. Hasselberg NE; Haugaa KH; Bernard A; Ribe MP; Kongsgaard E; Donal E; Edvardsen T Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):343-50. PubMed ID: 26164406 [TBL] [Abstract][Full Text] [Related]
3. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy. Risum N Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737 [TBL] [Abstract][Full Text] [Related]
5. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C; Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006 [TBL] [Abstract][Full Text] [Related]
6. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial). Adelstein E; Alam MB; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S Am J Cardiol; 2014 May; 113(9):1518-22. PubMed ID: 24630387 [TBL] [Abstract][Full Text] [Related]
7. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Kutyifa V; Kloppe A; Zareba W; Solomon SD; McNitt S; Polonsky S; Barsheshet A; Merkely B; Lemke B; Nagy VK; Moss AJ; Goldenberg I J Am Coll Cardiol; 2013 Mar; 61(9):936-44. PubMed ID: 23449428 [TBL] [Abstract][Full Text] [Related]
8. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results. Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404 [TBL] [Abstract][Full Text] [Related]
9. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only. Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878 [TBL] [Abstract][Full Text] [Related]
10. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833 [TBL] [Abstract][Full Text] [Related]
11. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study. Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860 [TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy. Abraham WT; León AR; St John Sutton MG; Keteyian SJ; Fieberg AM; Chinchoy E; Haas G Am Heart J; 2012 Nov; 164(5):735-41. PubMed ID: 23137504 [TBL] [Abstract][Full Text] [Related]
13. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954 [TBL] [Abstract][Full Text] [Related]
14. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E; J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490 [TBL] [Abstract][Full Text] [Related]
15. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D. Sebag FA; Lellouche N; Chen Z; Tritar A; O'Neill MD; Gill J; Wright M; Leclercq C; Rinaldi CA J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1368-75. PubMed ID: 25066404 [TBL] [Abstract][Full Text] [Related]
16. A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial. Krum H; Lemke B; Birnie D; Lee KL; Aonuma K; Starling RC; Gasparini M; Gorcsan J; Rogers T; Sambelashvili A; Kalmes A; Martin D Am Heart J; 2012 May; 163(5):747-752.e1. PubMed ID: 22607850 [TBL] [Abstract][Full Text] [Related]
17. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study. Gasparini M; Muto C; Iacopino S; Zanon F; Dicandia C; Distefano G; Favale S; Peraldo Neja C; Bragato R; Davinelli M; Mangoni L; Denaro A Am Heart J; 2012 Mar; 163(3):422-9. PubMed ID: 22424013 [TBL] [Abstract][Full Text] [Related]